The effectiveness of antidepressants and psychological interventions in treating conversion disorder, motor type: a randomized placebo controlled clinical trial. - Treatment of Conversion Disorder

GGZ Nijmegen (Nijmegen)0 个研究点目标入组 105 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•1) Current DSM-IV disorder of Conversion Disorder motor type as established with a structured diagnostic interview (MINI)
•2) Age minimum of 18 years
•3) Duration of symptoms at least one month
•4) Exclusive neurological examinations must have taken place (e.g. MRI, EMG, etc.) in which no neurological or other somatic explanation for the symptoms is found.

•1) A neurological disorder that can fully explain the symptoms as concluded by neurological examination (MRI, EMG, etc.)*
•2) Psychosis or delusion disorder (current or in the past)
•3) Suicidality
•4) Mental retardation
•5) Substance abuse or dependence
•6) Hypersensitivity to citalopram
•7)The use of citalopram currently or in the past when described in an adequate dosage to treat conversion symptoms
•8)The use of another SSRI (currently)
•9) Reduced hepatic or renal function
•10) Pregnancy and lactation
•11)The use of a drug which has known negative interaction effects with citalopram:
•a) MAO inhibiters (currently or recent)
•b) pimozide
•12) Difficulty to understand the Dutch language.
•* A concomitant neurological disorder is no exclusion criteria when symptoms are not fully explained by the condition and criteria for conversion disorder are met.

发起方

GGZ Nijmegen (Nijmegen)